Quantcast
Viewing latest article 24
Browse Latest Browse All 3110

Argenx’s Vyvgart Hytrulo syringe is approved in the US; Opthea to cut 65% of staff

Plus, news about Protagonist Therapeutics, Pfizer and Keros Therapeutics: Argenx wins FDA approval for Vyvgart Hytrulo syringe: The subcutaneous injection, which comes in a more convenient prefilled syringe, can be self-administered by the patient. Vyvgart ...

Viewing latest article 24
Browse Latest Browse All 3110

Trending Articles